Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 3,10-dihydroxy-2-naphthacene carboxamide or derivative doai
Patent
1994-12-13
1996-11-12
Rollins, John W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
3,10-dihydroxy-2-naphthacene carboxamide or derivative doai
514154, 514765, A61K 3165, A61K 31025
Patent
active
055740260
ABSTRACT:
The invention relates to a method for inhibiting angiogenesis and proliferation of endothelial cells by administering an inhibitory amount of a 7-halogen-9-[hydrogen or [(substituted glycyl)amido]]-6-demethyl-6-deoxytetracycline of Formula I: ##STR1## wherein X and W are as defined in the specification. The invention also relates to a method for inhibiting proliferation of tumor cells and tumor growth by administering an inhibitory amount of a compound of Formula I in combination with a chemotherapeutic agent or radiation therapy. The invention also relates to compositions containing an effective inhibitory amount of a compound of Formula I in a pharmaceutically acceptable carrier.
REFERENCES:
patent: 3226436 (1965-12-01), Petisi et al.
patent: 3518306 (1970-06-01), Martell et al.
patent: 5248797 (1993-09-01), Sum
patent: 5268384 (1993-12-01), Galardy
Guerin C. et al, Selective Endothelial Growth Inhibition by Tetracyclines that Inhibit Collagenase, Biochemical and Biophysical Research Communications, vol. 188, No. 2, 740-745, 1992.
Bogert C. van den, Arrest of in Vivo Proliferation of Zajdela Tumor Cells by Inhibition of Mitochondrial Protein Synthesis, Cancer Research 41, 1943-1947, May 1981.
Teicher, B. A. et al, Antiangiogenic Agents Potentiate Cytotoxic Cancer Therapeis against Primary and Metastatic Disease, Cancer Research, 52, 6702-6704, Dec., 1992.
Monks, A. et al, Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines, Journal of the National Cancer Institute, vol. 83, No. 11, 757-766, Jun., 1991.
Sotomayor, E. A. et al, Minocycline in combination with chemotherapy or radiation therapy in vitro and in vivo, Cancer Chemotherapy and Pharmacology, 30:377-384, 1992.
Leezenberg, J. A. et al, Possible Cytostatic Action of Tetracyclines in the Treatment of Tumors of the Nasopharynx and Larynx, European Journal of Clinical Pharmacology, 16, 237-241, 1979.
Tamargo, R. et al, Angiogenesis Inhibition by Minocycline, Cancer Research, 51, 672-675, Jan., 1991.
Kroon, A. M., The Antitumour Action of Doxycycline, Drugs Exptl. Clin. Res., X (11), 759-766, 1984.
Bogert C. van den, Arrest of the Proliferation of Renal and Prostate Carcinomas of Human Origin by Inhibition of Mitochondrial Protein Synthesis, Cancer Research, 46, 3283-3289, Jul., 1986.
Pruzandki, W. et al, Inhibition of Enzymatic Activity of Phospholipases A.sub.2 by Minocycline and Doxycycline, Biochemical Pharmacology, vol. 44, No. 6, 1165-1170, 1992.
Golub, L. M. et al, Host Modulation with Tetracyclines and their Chemically Modified Analogues, Periodontology and Restorative Dentistry, 80-90, 1992.
Golub, L. M. et al, Tetracyclines Inhibit Connective Tissue Breakdown: New Therapeutic Implications for an Old Family of Drugs, Critical Reviews in Oral Biology and Medicine, 2(2):297-322 (1991).
Kajigaeshi, S. et al, Iodination of Phenols by use of Benzyltrimethylammonium Dichloroiodate (10).sup.1), Chemistry Letters, (Japan) 2109-2112, 1987.
Kajigaeshi, S. et al, Hologenation Using Quaternary Ammonium Polyhalides. VI..sup.1) Bromination of Aromatic Amines by Use of Benzyltrimethylammonium Tribromide Bull Chem. Soc. Jpn., 61, 597-599, 1988.
Zucker, S. et al, Diversity of Melanoma Plasma Membrane Proteinases: Inhibition of Collagenoloytic and Cytoltic Activities by Minocycline, JNCI> vol. 75, No. 3, Sep. 1985.
Greenwald R. A., et al, Tetracyclines Inhibit Human Synovial Collagenase In Vivo and In Vitro, The Journal of Rhematology 1987: 14:1.
Hlavka, J. Et al, The 6-Deoxytetracyclines. III. Electrophilic and Nucleophilic Substitution J. Am.Chem Soc., 84, 1420, 1962.
Backer Joseph M.
Bohlen Peter
Sum Phaik-Eng
American Cyanamid Company
Rollins John W.
Szatkowski T. S.
LandOfFree
Methods for inhibiting angiogenesis proliferation of endothelial does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for inhibiting angiogenesis proliferation of endothelial, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for inhibiting angiogenesis proliferation of endothelial will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-562706